Literature DB >> 15884092

A three-factor model of the MADRS in major depressive disorder.

Akihito Suzuki1, Toshiaki Aoshima, Takashi Fukasawa, Keizo Yoshida, Hisashi Higuchi, Tetsuo Shimizu, Koichi Otani.   

Abstract

Major Depressive Disorder (MDD) may be composed of some symptom clusters with distinct neurochemical disturbances, suggesting the importance of the factor analysis of depressive symptoms; however, the results of previous studies using the Montgomery-Asberg Depression Rating Scale (MADRS) have been inconsistent. In the present study, factor analysis of the MADRS was performed in 132 Japanese patients (range 23-74 years, mean 47.6 years) with MDD without any psychiatric comorbidity. The principal component analysis with Varimax rotation identified three factors, accounting for 61% of the total variance: The first factor, labeled dysphoria, included pessimistic thoughts, suicidal thoughts, and reported sadness; the second factor, labeled retardation, included lassitude, inability to feel, apparent sadness, and concentration difficulties; and the third factor, labeled vegetative symptoms, included reduced sleep, reduced appetite, and inner tension. The score of the vegetative factor showed a significant positive correlation with age and was significantly higher in females than in males. This study suggests that the symptoms of MDD, as assessed by the MADRS, cluster into three factors (dysphoria, retardation, and vegetative symptoms). (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15884092     DOI: 10.1002/da.20058

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  19 in total

1.  Randomized Clinical Trial of Real-Time fMRI Amygdala Neurofeedback for Major Depressive Disorder: Effects on Symptoms and Autobiographical Memory Recall.

Authors:  Kymberly D Young; Greg J Siegle; Vadim Zotev; Raquel Phillips; Masaya Misaki; Han Yuan; Wayne C Drevets; Jerzy Bodurka
Journal:  Am J Psychiatry       Date:  2017-04-14       Impact factor: 18.112

2.  The factor structure of lifetime depressive spectrum in patients with unipolar depression.

Authors:  G B Cassano; A Benvenuti; M Miniati; S Calugi; M Mula; L Maggi; P Rucci; A Fagiolini; F Perris; E Frank
Journal:  J Affect Disord       Date:  2008-10-22       Impact factor: 4.839

Review 3.  Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia.

Authors:  Ibrahim Mohammed Badamasi; Munn Sann Lye; Normala Ibrahim; Johnson Stanslas
Journal:  J Neural Transm (Vienna)       Date:  2019-05-18       Impact factor: 3.575

4.  Executive functioning and risk-taking behavior in Parkinson's disease patients with impulse control disorders.

Authors:  Fanny Pineau; Emmanuel Roze; Lucette Lacomblez; Anne-Marie Bonnet; Marie Vidailhet; Virginie Czernecki; Jean-Christophe Corvol
Journal:  J Neural Transm (Vienna)       Date:  2016-04-16       Impact factor: 3.575

5.  The natural history of depressive symptoms in patients with incident Parkinson's disease: a prospective cohort study.

Authors:  Jan Petter Larsen; Ingvild Dalen; Kenn Freddy Pedersen; Ole-Bjørn Tysnes
Journal:  J Neurol       Date:  2017-10-14       Impact factor: 4.849

6.  Mixed-methods analysis of internalized stigma correlates in poorly adherent individuals with bipolar disorder.

Authors:  Molly Howland; Jennifer Levin; Carol Blixen; Curtis Tatsuoka; Martha Sajatovic
Journal:  Compr Psychiatry       Date:  2016-08-02       Impact factor: 3.735

7.  Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression.

Authors:  Brent P Forester; Chun S Zuo; Caitlin Ravichandran; David G Harper; Fei Du; Susan Kim; Bruce M Cohen; Perry F Renshaw
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-03       Impact factor: 2.680

8.  A Reexamination of Nonpsychiatric Medication Adherence in Individuals With Bipolar Disorder and Medical Comorbidities.

Authors:  Jennifer B Levin; Anna Krivenko; Ashley Bukach; Curtis Tatsuoka; Kristin A Cassidy; Martha Sajatovic
Journal:  J Nerv Ment Dis       Date:  2017-03       Impact factor: 2.254

9.  The structure of the Montgomery-Åsberg depression rating scale over the course of treatment for depression.

Authors:  Lena C Quilty; Jennifer J Robinson; Jean-Pierre Rolland; Filip De Fruyt; Frédéric Rouillon; R Michael Bagby
Journal:  Int J Methods Psychiatr Res       Date:  2013-08-19       Impact factor: 4.035

10.  Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression.

Authors:  Keiichiro Tominaga; Mioto Okazaki; Hisashi Higuchi; Itaru Utagawa; Etsuko Nakamura; Noboru Yamaguchi
Journal:  Int J Gen Med       Date:  2011-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.